353 related articles for article (PubMed ID: 23911424)
1. Gender-specific immunological effects of the phosphodiesterase 5 inhibitor sildenafil in healthy mice.
Karakhanova S; Yang Y; Link J; Soltek S; von Ahn K; Umansky V; Werner J; Bazhin AV
Mol Immunol; 2013 Dec; 56(4):649-59. PubMed ID: 23911424
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase 5 (PDE5) inhibition, ANP and NO rapidly reduce epididymal duct contractions, but long-term PDE5 inhibition in vivo does not.
Mietens A; Tasch S; Feuerstacke C; Eichner G; Volkmann J; Schermuly RT; Grimminger F; Müller D; Middendorff R
Mol Cell Endocrinol; 2012 Feb; 349(2):145-53. PubMed ID: 21996373
[TBL] [Abstract][Full Text] [Related]
4. Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ions.
Biswas KH; Visweswariah SS
J Biol Chem; 2011 Mar; 286(10):8545-8554. PubMed ID: 21193396
[TBL] [Abstract][Full Text] [Related]
5. Multiple affinity states of cGMP-specific phosphodiesterase for sildenafil inhibition defined by cGMP-dependent and cGMP-independent mechanisms.
Rybalkina IG; Tang XB; Rybalkin SD
Mol Pharmacol; 2010 Apr; 77(4):670-7. PubMed ID: 20086037
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Wharton J; Strange JW; Møller GM; Growcott EJ; Ren X; Franklyn AP; Phillips SC; Wilkins MR
Am J Respir Crit Care Med; 2005 Jul; 172(1):105-13. PubMed ID: 15817798
[TBL] [Abstract][Full Text] [Related]
8. Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries.
Kruuse C; Gupta S; Nilsson E; Kruse L; Edvinsson L
Eur J Pharmacol; 2012 Jan; 674(2-3):345-51. PubMed ID: 22094063
[TBL] [Abstract][Full Text] [Related]
9. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
Nagayama T; Zhang M; Hsu S; Takimoto E; Kass DA
J Pharmacol Exp Ther; 2008 Aug; 326(2):380-7. PubMed ID: 18456872
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of phosphodiesterase 5 enhances glutamatergic synaptic plasticity and memory in mice.
Uthayathas S; Parameshwaran K; Karuppagounder SS; Ahuja M; Dhanasekaran M; Suppiramaniam V
Synapse; 2013 Nov; 67(11):741-7. PubMed ID: 23620198
[TBL] [Abstract][Full Text] [Related]
11. Metal ion stimulators of PDE5 cause similar conformational changes in the enzyme as does cGMP or sildenafil.
Corbin JD; Foster TL; Bessay E; Busch J; Blount M; Francis SH
Cell Signal; 2011 May; 23(5):778-84. PubMed ID: 21187142
[TBL] [Abstract][Full Text] [Related]
12. The selective PDE5 inhibitor, sildenafil, improves object memory in Swiss mice and increases cGMP levels in hippocampal slices.
Rutten K; Vente JD; Sik A; Ittersum MM; Prickaerts J; Blokland A
Behav Brain Res; 2005 Oct; 164(1):11-6. PubMed ID: 16076505
[TBL] [Abstract][Full Text] [Related]
13. Transient rise of serum testosterone level after single sildenafil treatment of adult male rats.
Janjic MM; Stojkov NJ; Bjelic MM; Mihajlovic AI; Andric SA; Kostic TS
J Sex Med; 2012 Oct; 9(10):2534-43. PubMed ID: 22429315
[TBL] [Abstract][Full Text] [Related]
14. Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Klein T; Eltze M; Grebe T; Hatzelmann A; Kömhoff M
Cardiovasc Res; 2007 Jul; 75(2):390-7. PubMed ID: 17383621
[TBL] [Abstract][Full Text] [Related]
15. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats.
Bai Y; An R
Life Sci; 2015 Aug; 135():43-8. PubMed ID: 26006044
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil promotes adipogenesis through a PKG pathway.
Zhang X; Ji J; Yan G; Wu J; Sun X; Shen J; Jiang H; Wang H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1054-9. PubMed ID: 20471953
[TBL] [Abstract][Full Text] [Related]
18. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice.
Hoke NN; Salloum FN; Kass DA; Das A; Kukreja RC
Stem Cells; 2012 Feb; 30(2):326-35. PubMed ID: 22102597
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
20. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]